- OT
- Professional support
- Health services
- Moorfields Eye Hospital chief executive to take up UCL role
Moorfields Eye Hospital chief executive to take up UCL role
David Probert will become chief executive of University College London Hospitals in late summer
2 min read
23 February 2021
Moorfields Eye Hospital chief executive David Probert will leave his role in late summer to take up the position of chief executive at University College London Hospitals (UCLH).
Mr Probert served a close to five-year tenure at the eye hospital group, starting in the role in April 2016.
Moorfields chairman, Tessa Green, highlighted that Mr Probert has spent his career serving the NHS.
“Throughout his time at Moorfields, he has demonstrated a clear commitment and passion to ensuring our patients get access to the very best eye care they deserve both now and, thanks to Oriel our plans for a world class, modern treatment facility, for the future too,” she said.
Ms Green emphasised that under Mr Probert’s leadership Moorfields has maintained a position of strength both financially and in terms of its clinical reputation.
“David has also been instrumental in ensuring Moorfields continues to drive forward outstanding research through our partnership with the Institute of Ophthalmology at UCL, as well as building a strong executive leadership team,” she said.
Ms Green added that work to appoint Mr Probert’s successor will begin immediately.
Mr Probert described working for Moorfields as a “great privilege.”
“As we begin to rebuild our services following the pandemic and look to the future as we begin to develop a new five-year strategy, I feel that now is the right time for me to move on and to entrust the legacy of Moorfields to a new chief executive,” he said.
Mr Probert served a close to five-year tenure at the eye hospital group, starting in the role in April 2016.
Moorfields chairman, Tessa Green, highlighted that Mr Probert has spent his career serving the NHS.
“Throughout his time at Moorfields, he has demonstrated a clear commitment and passion to ensuring our patients get access to the very best eye care they deserve both now and, thanks to Oriel our plans for a world class, modern treatment facility, for the future too,” she said.
Ms Green emphasised that under Mr Probert’s leadership Moorfields has maintained a position of strength both financially and in terms of its clinical reputation.
“David has also been instrumental in ensuring Moorfields continues to drive forward outstanding research through our partnership with the Institute of Ophthalmology at UCL, as well as building a strong executive leadership team,” she said.
Ms Green added that work to appoint Mr Probert’s successor will begin immediately.
Mr Probert described working for Moorfields as a “great privilege.”
“As we begin to rebuild our services following the pandemic and look to the future as we begin to develop a new five-year strategy, I feel that now is the right time for me to move on and to entrust the legacy of Moorfields to a new chief executive,” he said.
Advertisement
Comments (0)
You must be logged in to join the discussion. Log in